These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8917023)

  • 21. [Nitric-oxide synthase inhibitor treatment in septic shock].
    Møller K; Skinhøj P
    Ugeskr Laeger; 2004 Mar; 166(11):1028-9. PubMed ID: 15049244
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shock.
    Price S; Evans TW; Mitchell JA
    Eur J Pharmacol; 2002 Aug; 449(3):279-85. PubMed ID: 12167470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yet another potential role for nitric oxide in the pathophysiology of septic shock.
    Sheehan M; Wong HR
    Crit Care Med; 2002 Jun; 30(6):1393-4. PubMed ID: 12072706
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
    Hussein Z; Beerahee M; Grover R; Jordan B; Jeffs R; Donaldson J; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
    Clin Pharmacol Ther; 1999 Jan; 65(1):1-9. PubMed ID: 9951425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide, sepsis and liver metabolism.
    Ceppi ED; Smith FS; Titheradge MA
    Biochem Soc Trans; 1997 Aug; 25(3):929-34. PubMed ID: 9388575
    [No Abstract]   [Full Text] [Related]  

  • 26. NO-synthase inhibition in sepsis.
    Spiel AO; Mayr FB
    Thromb Haemost; 2006 Apr; 95(4):591-2. PubMed ID: 16601826
    [No Abstract]   [Full Text] [Related]  

  • 27. Nitric oxide in critical care medicine.
    Cuthbertson BH; Webster NR
    Br J Hosp Med; 1995 Dec 13-1996 Jan 16; 54(11):579-82. PubMed ID: 8925150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overproduction of nitric oxide in cytokine-mediated and septic shock.
    Kilbourn RG; Griffith OW
    J Natl Cancer Inst; 1992 Jun; 84(11):827-31. PubMed ID: 1375655
    [No Abstract]   [Full Text] [Related]  

  • 29. Nitric oxide and septic shock.
    Cobb JP; Danner RL
    JAMA; 1996 Apr; 275(15):1192-6. PubMed ID: 8609688
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of nitric oxide on blood flow distribution and O2 extraction capabilities during endotoxic shock.
    Zhang H; Rogiers P; Smail N; Cabral A; Preiser JC; Peny MO; Vincent JL
    J Appl Physiol (1985); 1997 Oct; 83(4):1164-73. PubMed ID: 9338425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular biology: relevance of nitric oxide in vascular and nonvascular tissue with normal and decreased renal function.
    Blantz RC
    Blood Purif; 1994; 12(1):30-5. PubMed ID: 7527221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Petros A; Bennett D; Vallance P
    Lancet; 1991 Dec 21-28; 338(8782-8783):1557-8. PubMed ID: 1720856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide, in the gastric mucosa.
    Whittle BJ; Boughton-Smith NK; Moncada S
    Ann N Y Acad Sci; 1992; 664():126-39. PubMed ID: 1280930
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
    Nava E; Palmer RM; Moncada S
    Lancet; 1991 Dec 21-28; 338(8782-8783):1555-7. PubMed ID: 1683974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells.
    Mustafa SB; Howard KM; Olson MS
    Hepatology; 1996 Jun; 23(6):1622-30. PubMed ID: 8675186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Septic shock and nitric oxide].
    Lorente JA; Delgado MA; Landín L
    Enferm Infecc Microbiol Clin; 1997 Oct; 15 Suppl 3():14-9. PubMed ID: 9410077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of nitric oxide in autoimmunity.
    Vladutiu AO
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):1-11. PubMed ID: 7541734
    [No Abstract]   [Full Text] [Related]  

  • 39. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
    Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW
    Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reinforcement therapy using nitric oxide synthase inhibitors against endotoxin shock in dogs.
    Suga H; Nakagawa T; Soga Y; Deguchi Y; Suzuki T; Miyoshi N; Imamura Y; Fukuda M
    Surg Today; 2006; 36(9):811-7. PubMed ID: 16937286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.